Estimating the prevalence of cannabinoid use urine testing: A preliminary study in Kerman, Iran

This primary study was performed to determine the prevalence rate of cannabinoid consumed in Kerman (Iran). Urine samples of 700 males, referred to a clinical lab in Kerman city were collected for detection of cannabinoid metabolites. Assessment analysis was a monophasic immunoassay rapid technique....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Addictive behaviors 2005-08, Vol.30 (7), p.1464-1467
Hauptverfasser: Meimandi, Manzume Shamsi, Nakhaee, Nouzar, Divsalar, Kouros, Dabiri, Shahriar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This primary study was performed to determine the prevalence rate of cannabinoid consumed in Kerman (Iran). Urine samples of 700 males, referred to a clinical lab in Kerman city were collected for detection of cannabinoid metabolites. Assessment analysis was a monophasic immunoassay rapid technique. The study was completely blind and only age and residence of samples were revealed. All stages were confirmed and supervised by the ethics committee. The prevalence of cannabinoid use was 0.6%. All four positive cases were urban, with ages 31, 36, 40 and 67. More than 90% of referred cases were urban with mean age of 46.8±16 while the mean age of rural cases was 54.3±17 years. Considering the age range and possibility of the underlying disease in the study population, the prevalence of cannabinoid use was more than what was expected. Urine analysis as a method for assessing the prevalence rate requires a wide sample size and age distribution matching the age distribution of the study population. In addition, the entrance criteria should not include sick cases.
ISSN:0306-4603
1873-6327
DOI:10.1016/j.addbeh.2005.01.016